One study found that patients with anti-thyroid antibodies after ipilimumab treatment developed significantly more thyroid dysfunction compared with those without antibodies, and interestingly, these antibody-positive patients showed a trend toward improved survival [ 39 ].
← all excerpts
Plasma exchange for severe immune-related adverse events from checkpoint inhibitors: an early window of opportunity?
1
—
—